Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

Jennet Harvey, G.M. Clark, C.K. Osborne, D.C. Allred

    Research output: Contribution to journalArticlepeer-review

    1841 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer'. Together they form a unique fingerprint.

    Nursing and Health Professions

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science